FrancophonIA/ELRC3.0 huggingface dataset:
English: The 5'-glucuronide of zidovudine is the major metabolite in both plasma and urine, accounting for approximately 50-80 % of the administered dose eliminated by renal excretion.
Croatian: Glavni metabolit zidovudina u plazmi i urinu je 5'-glukuronid i u tom se obliku bubrezima izlučuje 5080% primijenjene doze lijeka.
English: Very common: Nausea
Croatian: Vrlo često: mučnina
English: • stavudine or zalcitabine, to treat HIV infection
Croatian: • stavudin ili zalcitabin, za liječenje infekcije HIV-om
English: A bioequivalence study compared lamivudine/zidovudine with lamivudine 150 mg and zidovudine 300 mg tablets taken together.
Croatian: U studiji bioekvivalencije uspoređivao se lamivudin/zidovudin s lamivudinom 150 mg i zidovudinom 300 mg u obliku tableta, uzimanih zajedno.
English: Renal clearance of zidovudine is estimated to be 0.34 l/h/kg, indicating glomerular filtration and active tubular secretion by the kidneys.
Croatian: Renalni klirens z idovudina pr ocijenjen je na 0,3 4 l/h/kg, ukazujući na pretežno izlučivanje glomerularnom filtracijom i a ktivnom t ubularnom s ekrecijom.
English: Trimethoprim/sulfamethoxazole (Co-trimoxazole)/Lamivudine (160 mg/800 mg once daily for 5 days/300 mg single dose)
Croatian: Lamivudina/Zidovudina Teva i klaritromicina kroz najmanje 2 sata trimetoprim/sulfametoksazol (kotrimoksazol)/lamivudin (160 mg/800 mg jedanput dnevno tijekom 5 dana/300 mg jednokratna doza)
English: Rare side effects that may show up in blood tests are:
Croatian: Rijetke nuspojave koje se mogu pojaviti u krvnim pretragama su:
English: Skin and subcutaneous tissue disorders Common: Rash, alopecia Rare: Angioedema
Croatian: Poremećaji kože i potkožnog tkiva: Često: osip, alopecija Rijetko: angioedem
English: Studies in patients with renal impairment show lamivudine elimination is affected by renal dysfunction.
Croatian: Studije na bolesnicima s oštećenjem bubrega pokazuju da disfunkcija bubrega utječe na eliminaciju lamivudina.
English: Zidovudine AUC ↓48% (UGT induction)
Croatian: zidovudin AUC ↓48% (UGT indukcija)
English: Zidovudine AUC ↑106% (UGT inhibition)
Croatian: zidovudin AUC ↑106% (UGT inhibicija)
English: In HIV-infected patients with severe immune deficiency at the time of initiation of combination antiretroviral therapy (CART), an inflammatory reaction to asymptomatic or residual opportunistic infections may arise.
Croatian: U bolesnika zaraženih virusom HIV-a koji u trenutku započinjanja kombiniranog antiretrovirusnog liječenja imaju teški imunološki deficit, može se razviti upalna reakcija na asimptomatske ili rezidualne oportunističke infekcije.
English: Rare: Oral mucosa pigmentation, taste perversion and dyspepsia.
Croatian: Rijetko: pigmentacija oralne sluznice, promjene osjeta okusa i dispepsija, pankreatitis
English: Potential to slightly decrease zidovudine plasma concentrations through UGT induction.
Croatian: Potencijalno lagano smanjivanje koncentracije zidovudina u plazmi zbog UGT indukcije fenitoin/lamivudin
English: Based on these data lamivudine/zidovudine may be administered with or without food.
Croatian: Na osnovu ovih podataka, ustanovljeno je da se lamivudin/zidovudin može uzimati sa i bez hrane.
English: When you are being treated for HIV, it can be hard to tell whether a symptom is a side effect of Lamivudine/Zidovudine Teva or other medicines you are taking, or an effect of the HIV disease itself.
Croatian: U liječenju HIV infekcije nije uvijek moguće odrediti jesu li neke nuspojave uzrokovane Lamivudinom/ZidovudinomTeva, drugim istodobno primijenjenim lijekovima ili su posljedica same bolesti.
English: Therefore as dosage adjustment of these may be necessary it is recommended that separate preparations of lamivudine and zidovudine be administered to patients with reduced renal function (creatinine clearance ≤50 ml/min).
Croatian: Stoga se, zbog moguće potrebe prilagodbe doze, bolesnicima sa smanjenom funkcijom bubrega (klirens kreatinina ≤50 ml/min) preporučuje davanje odvojenih pripravaka lamivudina i zidovudina.
English: In these cases the physician should refer to the individual prescribing information for these medicinal products.
Croatian: U tim slučajevima liječnik treba proučiti Sažetke opisa svojstava lijeka za svaki od ova dva lijeka.
English: Lactic acidosis: Lactic acidosis usually associated with hepatomegaly and hepatic steatosis has been reported with the use of zidovudine.
Croatian: Laktacidoza: Kod primjene zidovudina zabilježena je laktacidoza koja je obično udružena s hepatomegalijom i steatozom jetre.
English: • drowsiness
Croatian: • utrnulost
English: Lamivudine demonstrates low cytotoxicity to peripheral blood lymphocytes, to established lymphocyte and monocyte-macrophage cell lines, and to a variety of bone marrow progenitor cells in vitro.
Croatian: Lamivudin pokazuje nisku citoksičnost prema perifernim limfocitima, prema diferenciranim staničnim linijama limfocita i monocita-makrofaga i prema brojnim progenitornim stanicama koštane srži u in vitro uvjetima.
English: Lamivudine/Zidovudine Teva can make you dizzy and have other side effects that make you less alert.
Croatian: Od Lamivudina/Zidovudina Teva možete osjećati omaglicu ili druge nuspojave koje Vam mogu smanjiti pažnju.
English: Weight and levels of blood lipids and glucose may increase during antiretroviral therapy (see section 4.4).
Croatian: Tijekom antiretrovirusne terapije mogu se povećati tjelesna težina i povisiti razine lipida i glukoze u krvi (vidjeti dio 4.4).
English: Hepatic impairment: Limited data in patients with cirrhosis suggest that accumulation of zidovudine may occur in patients with hepatic impairment because of decreased glucuronidation.
Croatian: Oštećenje jetre: Oskudni podaci kod bolesnika s cirozom jetre ukazuju na mogućnost nakupljanja zidovudina u bolesnika s oštećenjem jetre, uslijed smanjene glukuronidacije.
English: As dosage adjustment of Lamivudine/Zidovudine Teva is not possible, separate preparations of zidovudine and lamivudine should be used.
Croatian: Kako prilagodba doze Lamivudina/Zidovudina Teva nije moguća, potrebno je primijeniti odvojene pripravke zidovudina i lamivudina.
English: Very common side effects These may affect more than 1 in 10 people:
Croatian: Vrlo česte nuspojave Mogu se pojaviti u više od 1 na 10 osoba:
English: Take special care with Lamivudine/Zidovudine Teva
Croatian: Budite posebno oprezni s Lamivudinom/Zidovudinom Teva
English: In patients with early HIV disease haematological adverse reactions are infrequent.
Croatian: U bolesnika koji su u ranoj fazi HIV bolesti hematološke nuspojave su manje česte.
English: Combination therapy for HIV can also cause: • increased levels of lactic acid in the blood, which on rare occasions can lead to lactic acidosis.
Croatian: • povišene razine mliječne kiseline u krvi koje u rijetkim slučajevima mogu dovesti do laktacidoze
English: Cssmax levels were 4.45 μM (1.19 μg/ml) following a dose of 120 mg zidovudine (in solution)/m2 body surface area and 7.7 μM (2.06 μg/ml) at 180 mg/m2 body surface area.
Croatian: Vrijednosti CSSmax su bile 4,45 μM (1,19 μg/ml) nakon primjene 120 mg zidovudina (u otopini)/m površine tijela,
English: As well as the side effects listed below for Lamivudine/Zidovudine Teva, other conditions can develop during combination therapy for HIV.
Croatian: Osim nuspojava navedenih dolje za Lamivudin/Zidovudin Teva, za vrijeme kombinirane terapije za HIV, mogu se razviti i druge nuspojave.
English: What you need to know before you take Lamivudine/Zidovudine Teva Do not take Lamivudine/Zidovudine Teva
Croatian: Što morate znati prije nego počnete uzimati Lamivudin/Zidovudin Teva
English: Recommendation concerning co-administration
Croatian: Preporuke za istodobnu primjenu
English: Lamivudine/Zidovudine Teva may be administered with or without food.
Croatian: Lamivudin/Zidovudin Teva se može uzimati sa ili bez hrane.
English: Intravenous studies with lamivudine and zidovudine showed that the mean apparent volume of distribution is 1.3 and 1.6 l/kg respectively.
Croatian: U intravenskim studijama izmjerene su srednje vrijednosti prividnog volumena raspodjele od 1,3 l/kg za lamivudin i 1,6 l/kg za zidovudin.
English: Zidovudine AUC ↑80% (UGT inhibition)
Croatian: zidovudin AUC ↑80% (UGT inhibicija)
English: Adverse reactions have been reported during therapy for HIV disease with lamivudine and zidovudine separately or in combination.
Croatian: Prijavljene su nuspojave tijekom liječenja HIV bolesti lamivudinom, zidovudinom kao i kombinacijom ovih dvaju lijekova.
English: Zidovudine AUC ↑74% (UGT inhibition)
Croatian: zidovudin AUC ↑74% (UGT inhibicija)
English: Cellulose, microcrystalline Sodium starch glycolate (Type A) Sodium stearyl fumarate
Croatian: Jezgra tablete celuloza, mikrokristalična natrijev škroboglikolat (vrste A) natrijev stearilfumarat
English: The combination of lamivudine with cladribine is not recommended (see section 4.5).
Croatian: Ne preporučuje se uzimanje lamivudina sa kladribinom (vidjeti dio 4.5).
English: Indeed, the available clinical data are very limited and preclude any reliable conclusion in the field.
Croatian: Klinički značaj navedenog nije utvrđen; klinički podaci su oskudni i onemogućavaju pouzdane zaključke.
English: Lamivudine/Zidovudine Teva 150 mg/300 mg film-coated tablets lamivudine/zidovudine
Croatian: Lamivudin/Zidovudin Teva 150 mg/300 mg filmom obložene tablete lamivudin/zidovudin
English: The usual starting dose of Lamivudine/Zidovudine Teva is one half tablet (½) taken in the morning and one half tablet (½) taken in the evening.
Croatian: Teva je pola (½) tablete ujutro i pola (½) tablete navečer.
English: Talk to your doctor if any of these apply to you.
Croatian: Vašeg liječnika ako se išta od navedenog odnosi na Vas.
English: • muscle weakness.
Croatian: • slabost mišića.
English: - The active substances are lamivudine 150 mg and zidovudine 300 mg. - The other ingredients are: Tablet core: Cellulose microcrystalline, sodium starch glycolate (Type A), sodium stearyl fumarate.
Croatian: - Pomoćne tvari su: Jezgra tablete: Celuloza, mikrokristalična, natrijev škroboglikolat (vrste A), n atrijev st earilfumarat.
English: • wind (flatulence)
Croatian: • vjetrovi (nadutost)
English: Respiratory, thoracic and mediastinal disorders Common: Cough, nasal symptoms
Croatian: Poremećaji dišnog sustava, prsišta i sredoprsja: Često: kašalj, simptomi rinitisa
English: MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE
Croatian: PROIZVOĐAČ(I) ODGOVORNI ZA PUŠTANJE SERIJE LIJEKA U PROMET
English: Uncommon: Fever, generalised pain and asthenia Rare: Chills, chest pain and influenza-like syndrome
Croatian: Rijetko: zimica, bolovi u prsnom košu i sindrom nalik gripi
English: Musculoskeletal and connective tissue disorders Common: Myalgia
Croatian: Poremećaji mišićno-koštanog sustava i vezivnog tkiva Često: mijalgija
English: Common: Vomiting, abdominal pain and diarrhoea Uncommon: Flatulence
Croatian: Često: povraćanje, bol u abdomenu i proljev Manje često: flatulencija
English: Zidovudine is contraindicated in patients with abnormally low neutrophil counts (<0.75 x 109/l), or abnormally low haemoglobin levels (<7.5 g/dl or 4.65 mmol/l).
Croatian: 9/l), il i s izrazito niskom razinom hemoglobina (<7,5 g/dl ili 4,65 mmol/l).
English: Therefore the concomitant use of lamivudine with cladribine is not recommended (see section 4.4)
Croatian: Stoga se ne preporučuje istodobna primjena kladribina i lamivudina (vidjeti dio 4.4).
English: • amphotericin or co-trimoxazole, to treat fungal and bacterial infections
Croatian: • amfotericin ili kotrimoksazol, za liječenje gljivičnih i bakterijskih infekcija
English: As only limited data are available the clinical significance is not known.
Croatian: Zbog ograničenih podataka nije poznata klinička važnost.
English: The clinical significance of these findings is unknown.
Croatian: Klinička značajnost ovih nalaza nije poznata.
English: If you take more Lamivudine/Zidovudine Teva than you should
Croatian: Ako uzmete više Lamivudina/Zidovudina
English: Tablet film-coat Hypromellose 3cP Hypromellose 6cP Polysorbate 80
Croatian: Film ovojnica tablete hipromeloza 3cP hipromeloza 6cP polisorbat 80 makrogol 400 titanijev dioksid (E171)
English: Haematological adverse reactions: Anaemia, neutropenia and leucopenia (usually secondary to neutropenia) can be expected to occur in patients receiving zidovudine.
Croatian: Hematološke nuspojave: U bolesnika koji primaju zidovudin, može se očekivati pojava anemije, neutropenije i leukopenije (obično kao posljedica neutropenije).
English: Atovaquone/Zidovudine (750 mg twice daily with food/200 mg thrice daily)
Croatian: atovakvon/zidovudin (750 mg dva puta dnevno uz hranu/200 mg tri puta dnevno)
English: Clarithromycin/Lamivudine
Croatian: klaritromicin/lamivudin
English: 3'-amino-3'deoxythymidine (AMT) has been identified as a metabolite of zidovudine following intravenous dosing.
Croatian: Zidovudin se nakon intravenske primjene jednim dijelom metabolizira u 3'-amino-3'-deoksitimidin (AMT).
English: What Lamivudine/Zidovudine Teva is and what it is used for Lamivudine/Zidovudine Teva is used to treat HIV (human immunodeficiency virus) infection in adults and children.
Croatian: Lamivudin/Zidovudin Teva je namijenjen liječenju infekcija HIV-om (virusom humane imunodeficijencije) u odraslih bolesnika i djece.
English: • cladribine, used to treat hairy cell leukaemia
Croatian: • kladribin, koristi se za liječenje leukemije vlasastih stanica Obavijestite
English: Each film-coated tablet contains 150 mg lamivudine and 300 mg zidovudine.
Croatian: - Djelatne tvari su 150 mg lamivudina i 300 mg zidovudina.
English: Clarithromycin/Zidovudine (500 mg twice daily/100 mg every 4 hours)
Croatian: Odvojena primjena klaritromicin/zidovudin (500 mg dva puta dnevno/ 100 mg svakih 4 sata)
English: Adults and adolescents weighing at least 30 kg: the recommended oral dose of Lamivudine/Zidovudine Teva is one tablet twice daily.
Croatian: Odrasli i adolescenti tjelesne težine najmanje 30 kg: preporučena oralna doza Lamivudina/Zidovudina
English: Lamivudine/zidovudine was shown to be bioequivalent to lamivudine 150 mg and zidovudine 300 mg given as separate tablets, when administered to fasting subjects.
Croatian: Pokazano j e d a j e lamivudin/zidovudin bioekvivalentan lamivudinu od 150 mg i zidovudinu od 300 mg ako se daju bolesnicima natašte kao odvojene tablete.
English: • stomach pain.
Croatian: • bol u trbuhu.
English: Probenecid/Zidovudine (500 mg four times daily/2 mg/kg thrice daily)
Croatian: probenecid/zidovudin (500 mg četiri puta dnevno/ 2 mg/kg triputa dnevno)
English: Blood and lymphatic system disorders Common: Anaemia, neutropenia and leucopenia Uncommon: Thrombocytopenia and pancytopenia (with marrow hypoplasia) Rare: Pure red cell aplasia
Croatian: Često: anemija, neutropenija i leukopenija Manje često: trombocitopenija i pancitopenija (s hipoplazijom koštane srži) Rijetko: aplazija crvenih krvnih stanica Vrlo rijetko: aplastična anemija
English: The mean ratios of CSF/serum lamivudine and zidovudine concentrations 2-4 hours after oral administration were approximately 0.12 and 0.5 respectively.
Croatian: S rednji om jer k oncentracija l amivudina u likvoru i s erumu 2 -4 sat a n akon o ralne p rimjene iznosi oko 0,12, a zidovudina 0,5.
English: PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING CONTAINERS
Croatian: ODACI KOJI SE MORAJU NALAZITI NA UNUTARNJEM PAKIRANJU SPREMNICI
English: Marketing Authorisation Holder and Manufacturer Marketing Autnorisation Holder
Croatian: Nositelj odobrenja za stavljanje lijeka u promet i proizvođač
English: Combination therapy such as Lamivudine/Zidovudine Teva may cause other conditions to develop during HIV treatment.
Croatian: Ostale moguće nuspojave kombinirane terapije HIV-a Kombinirana terapija kao što je Lamivudin/Zidovudin Teva može uzrokovati druga stanja koja se mogu razviti za vrijeme liječenja HIV-a.
English: Phenobarbital/Zidovudine
Croatian: fenobarbital/zidovudin
English: Other possible side effects of combination therapy for HIV
Croatian: Ostali učinci koji se mogu pojaviti u krvnim pretragama Kombinirana terapija za HIV može isto tako uzrokovati:
English: Didanosine /Zidovudine
Croatian: didanozin/zidovudin
English: The usual starting dose of Lamivudine/Zidovudine Teva is one half tablet (½) taken in the morning and one whole tablet taken in the evening.
Croatian: Teva je pola (½) tablete ujutro, a jedna cijela tableta navečer.
English: The safety and efficacy of zidovudine has not been established in patients with significant underlying liver disorders.
Croatian: U bolesnika s ozbiljnom postojećom bolešću jetre nije ustanovljena sigurnost i djelotvornost zidovudina.
English: The malformative risk is unlikely in humans based on the mentioned large amount of data.
Croatian: Uzimajući u obzir spomenutu veliku količinu podataka, rizik od malformacija kod ljudi je malo vjerojatan.
English: General disorders and administration site conditions Common: Malaise
Croatian: Opći poremećaji i reakcije na mjestu primjene Često: malaksalost
English: Rare side effects These may affect up to 1 in 1000 people:
Croatian: Rijetke nuspojave Mogu se pojaviti u manje od 1 na 1000 osoba:
English: Rifampicin/Zidovudine (600 mg once daily/200 mg thrice daily)
Croatian: rifampicin/zidovudin (600 mg jedanput dnevno/200 mg tri puta dnevno)
English: There were no other zidovudine-related tumours observed in either sex of either species.
Croatian: N isu z abilježene dr uge ne oplazme vezane uz primjenu zidovudina u bilo kojeg spola obje vrste.
English: Physicians should refer to the individual prescribing information for these medicinal products.
Croatian: Liječnici trebaju proučiti Sažetke opisa svojstava lijeka za svaki od ova dva lijeka.
English: As only limited data available the clinical significance is unknown.
Croatian: Dostupni su samo ograničeni podaci te klinička značajnost nije poznata.
English: No Lamivudine/Zidovudine Teva dosage adjustment necessary, unless patient has renal impairment (See Section
Croatian: Lamivudina/Zidovudina Teva, osim ako bolesnik ima oštećenje bubrega (vidjeti dio 4.2).
English: • high doses of co-trimoxazole, an antibiotic.
Croatian: • visoke doze antibiotika kotrimoksazola
English: Lamivudine/Zidovudine Teva 150 mg/300 mg film-coated tablets
Croatian: NAZIV LIJEKA Lamivudin/Zidovudin Teva 150 mg/300 mg filmom obložene tablete
English: Stavudine/Zidovudine
Croatian: stavudin/zidovudin
English: Lamivudine/Zidovudine Teva helps to control your condition.
Croatian: Ostanite u redovitom kontaktu s Vašim liječnikom Lamivudin/Zidovudin Teva Vam pomaže da kontrolirate stanje bolesti.
English: Children weighing from 14 kg to 21 kg: the recommended oral dose of Lamivudine/Zidovudine Teva is one-half tablet taken twice daily.
Croatian: Djeca s tjelesnom težinom od 14 kg do 21 kg: preporučena oralna doza Lamivudina/Zidovudina
English: • feeling breathless
Croatian: • osjećaj nedostatka zraka
English: Lamivudine is predominately cleared unchanged by renal excretion.
Croatian: Lamivudin se najvećim dijelom izlučuje iz organizma putem bubrega, u nepromijenjenom obliku.
English: Uncommon: Neutropenia and anaemia (both occasionally severe), thrombocytopenia Very rare: Pure red cell aplasia
Croatian: Manje često: neutropenija i anemija (obje ponekad teške), trombocitopenija
English: Stavudine/Lamivudine
Croatian: stavudin/lamivudin
English: Fluconazole/Zidovudine (400 mg once daily/200 mg thrice daily)
Croatian: flukonazol/zidovudin (400 mg jedanput dnevno/ 200 mg triput dnevno)
English: URICOSURIC
Croatian: • proljev
English: General disorders and administration site conditions Common: Fatigue, malaise, fever
Croatian: Opći poremećaji i reakcije na mjestu primjene Često: umor, malaksalost, vrućica
English: Very rare: Aplastic anaemia
Croatian: Vrlo rijetko: aplazija crvenih krvnih stanica
English: • stiffness in the joints
Croatian: • ukočenost zglobova
English: There is limited experience of overdosage with lamivudine/zidovudine.
Croatian: Iskustvo s pr edoziranjem Lamivudinom/Zidovudinom T eva je ograničeno.
English: Valproic acid/Zidovudine (250 mg or 500 mg thrice daily/100 mg thrice daily)
Croatian: valproična kiselina/zidovudin (250 mg ili 500 mg tri puta dnevno/100 mg tri puta dnevno)
English: Very rare side effects These may affect up to 1 in 10,000 people
Croatian: Vrlo rijetke nuspojave Mogu se pojaviti u manje od 1 na 10 000 osoba:
English: How to store Lamivudine/Zidovudine Teva
Croatian: Kako uzimati Lamivudin/Zidovudin Teva
English: Ranitidine/Lamivudine
Croatian: ranitidin/lamivudin
English: Cimetidine/Lamivudine
Croatian: cimetidin/lamivudin
English: Skin and subcutaneous tissue disorders Uncommon: Rash and pruritus Rare: Nail and skin pigmentation, urticaria and sweating
Croatian: Poremećaji kože i potkožnog tkiva Manje često: osip i svrbež
English: As Lamivudine/Zidovudine Teva contains lamivudine and zidovudine, the type and severity of adverse reactions associated with each of the compounds may be expected.
Croatian: Budući da Lamivudin/Zidovudin Teva sadrži i lamivudin i zidovudin, mogu se očekivati nuspojave karakteristične za oba lijeka.
English: Lamivudine is cleared renally.
Croatian: Lamivudin se uklanja putem bubrega.
English: EXP
Croatian: • osip
English: Uncommon side effects These may affect up to 1 in 100 people:
Croatian: Manje česte nuspojave Mogu se pojaviti u manje od 1 na 100 osoba:
English: Additionally dosage adjustment of zidovudine may be required if severe anaemia or myelosuppression occurs during treatment with Lamivudine/Zidovudine Teva, or in patients with preexisting bone marrow compromise e.g. haemoglobin <9 g/dl (5.59 mmol/l) or neutrophil count <1.0 x 10
Croatian: Mogu biti potrebne dodatne prilagodbe doziranja zidovudina u slučaju pojave teške anemije ili mijelosupresije za vrijeme liječenja s Lamivudinom/Zidovudinom Teva, ili u bolesnika s postojećom bolesti koštane srži,
English: In oral carcinogenicity studies with zidovudine in mice and rats, late appearing vaginal epithelial tumours were observed.
Croatian: U i spitivanjima k ancerogenosti p eroralne p rimjene z idovudina n a m iševima i š takorima o pažena je kasna pojava tumora vaginalnog epitela.
English: Cimetidine/Zidovudine
Croatian: cimetidin/zidovudin
English: Pancreatitis
Croatian: Dojenje
English: Methadone/Lamivudine
Croatian: OPIOIDI metadon/lamivudin
English: Ranitidine/Zidovudine
Croatian: ranitidin/zidovudin
English: Common side effects These may affect up to 1 in 10 people:
Croatian: Česte nuspojave Mogu se pojaviti u manje od 1 na 10 osoba:
English: Phenobarbital/Lamivudine
Croatian: ANTIEPILEPTICI fenobarbital/lamivudin
English: Fluconazole/Lamivudine
Croatian: ANTIMIKOTICI flukonazol/lamivudin
English: Some medicines interact with Lamivudine/Zidovudine Teva
Croatian: Neki lijekovi imaju interakciju s Lamivudinom/Zidovudinom Teva Oni uključuju:
English: In long-term oral carcinogenicity studies in rats and mice, lamivudine did not show any carcinogenic potential.
Croatian: U dug otrajnim i spitivanjima or alne k ancerogenosti u š takora i m iševa, l amivudin n ije pok azao kancerogeni potencijal.
English: Common: Dizziness
Croatian: Često: omaglica
English: Common side effects that might show up in blood tests are:
Croatian: Česte nuspojave koje se mogu javiti u krvim pretragama:
English: CYTOTOXICS Cladribine/Lamivudine
Croatian: CITOTOKSICI Kladribin/lamivudin
English: If you get any symptoms of infection while you are taking Lamivudine/Zidovudine Teva:
Croatian: Ako zadobijete bilo koji od ovih simptoma prilikom uzimanja Lamivudina/Zidovudina Teva: Odmah obavijestite liječnika.
English: Treatment with Lamivudine/Zidovudine Teva should be stopped immediately if clinical signs, symptoms or laboratory abnormalities suggestive of pancreatitis occur.
Croatian: Ukoliko se jave klinički znakovi, simptomi ili abnormalni laboratorijski nalazi koji ukazuju na pankreatitis, treba smjesta prekinuti liječenje Lamivudinom/Zidovudinom Teva.
English: When concomitant administration with cotrimoxazole is warranted, patients should be monitored clinically.
Croatian: Kada je neizbježna istodobna primjena s kotrimoksazolom,
English: Each film-coated tablet contains lamivudine 150 mg zidovudine 300 mg
Croatian: KVALITATIVNI I KVANTITATIVNI SASTAV Jedna filmom obložena tableta sadrži 150 mg lamivudina i 300 mg zidovudina.